Extranodal Nk T-cell Lymphoma Non-nasal Type
📧 Sign up to get email alerts when something new happens for Extranodal Nk T-cell Lymphoma Non-nasal Type.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma [Phase 2]
A Phase 2 trial compares adding golidocitinib to a P-GemOx regimen plus a PD-1 inhibitor against P-GemOx plus a PD-1 inhibitor as first-line…